Dow Down 0.48% Nasdaq Up 0.29%

Biogen Inc. (BIIB)

-NasdaqGS
289.73 Up 6.94(2.45%) 4:00PM EDT
|After Hours : 289.70 Down 0.03 (0.01%) 7:13PM EDT
Prev Close:282.79
Open:285.00
Bid:289.65 x 900
Ask:290.55 x 100
1y Target Est:345.50
Beta:0.3261
Earnings Date:Jul 22 - Jul 26 (Est.)
Day's Range:284.66 - 291.63
52wk Range:242.07 - 420.99
Volume:2,146,497
Avg Vol (3m):1,625,170
Market Cap:63.47B
P/E (ttm):17.81
EPS (ttm):16.27
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for BIIB

Comparison

Symbol% ChgMkt Cap
BIIBUp 2.45%63.47B
PFEUp 0.26%210.45B
ABTUp 0.84%58.22B

Key Statistics

Forward P/E (1 yr):14.44
P/S (ttm):5.66
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :18.85
Quarterly EPS Est (Jun-16) :4.68
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):1.92

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Biogen Inc. discovers, develops, manufactures, and delivers therapies for the treatment of neurodegenerative diseases, hematologic conditions, and autoimmune disorders. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback